All HHS Contracts — September 10, 2026

A single $1.01B defense contract from HHS to ADVANCED TECHNOLOGY INTERNATIONAL represents 69% of total contract value, signaling a major, potentially sole-source relationship. However, the lack of pricing type, competition details, and revenue estimates creates high ambiguity.

SparkSoft, a minority-owned small business, won a $41.4M firm-fixed-price delivery order from CMS for IT testing services through 2024, with potential total value of $46.1M. The full-and-open competition win against larger firms signals strong execution capability.

Leidos Biomedical Research's $79.9M cost-plus-fixed-fee contract for the SeroNet program runs through October 2026, with outlays already exceeding base value at $82.7M. The approaching end date creates a re-compete catalyst for Leidos or competitors.

CIVICACTIONS' $41.5M firm-fixed-price CMS contract has options potentially expanding total value to $73.4M through 2029, representing 77% potential upside if all options are exercised. The full-and-open competition win suggests competitive pricing.

The $1.01B ADVANCED TECHNOLOGY INTERNATIONAL contract accounts for 69% of total $1.46B obligation, creating extreme single-contract concentration risk. Any protest, re-compete loss, or budget cut would materially impact the aggregate picture.

SparkSoft Corporation's $41.4M firm-fixed-price CMS contract carries medium execution risk, as cost overruns would directly impact margins. The contract's 2024 end date is already past, raising questions about follow-on work or extensions.

Five contracts totaling ~$304M from NIH/NIAID and BARDA (Leidos, BIOQUAL, Fisher, JHU/APL, Draper) are cost-plus-fixed-fee, providing stable but capped margins. Any NIH budget cuts under CR or political pressure would reduce future option exercises.

CIVICACTIONS' $41.5M CMS web services contract with potential $73.4M total value through 2029 signals growing CMS investment in digital modernization. Follow-on contracts for web experience and content management could benefit IT services firms.

The $1.01B ADVANCED TECHNOLOGY INTERNATIONAL defense contract from HHS suggests a new or expanding defense-health nexus. Investors should watch for similar cross-agency defense contracts awarded to other health R&D firms.

SparkSoft Corporation, a minority-owned small business, won a $41.4M full-and-open competition CMS contract without set-aside, demonstrating ability to compete against larger firms. This could signal future small business wins in CMS IT services.

Five of nine contracts ($304M total) are from NIH/NIAID and BARDA for health R&D, serological sciences, vaccine support, and medical countermeasures, reflecting sustained bipartisan investment in pandemic preparedness post-COVID.

Two contracts totaling $82.8M to CIVICACTIONS and SparkSoft Corporation for web services and IT quality control signal CMS's ongoing digital transformation, with potential option-driven upside to $119.5M.

{"entity" => "ADVANCED TECHNOLOGY INTERNATIONAL", "reason" => "The $1.01B contract is opaque and represents 69% of total value; any protest, modification, or re-compete would be material.", "trigger" => "GAO protest filing, contract modification announcement, or FY2027 HHS defense budget line item"}

{"entity" => "Leidos Holdings, Inc.", "reason" => "Leidos Biomedical Research's $79.9M NIH SeroNet contract ends October 2026; re-compete outcome will signal competitive position.", "trigger" => "NIH SeroNet re-compete solicitation or award announcement"}

{"entity" => "CIVICACTIONS, INC.", "reason" => "CMS option exercise decisions on $73.4M potential contract value will determine revenue trajectory.", "trigger" => "CMS option exercise announcements for 2027-2029"}

{"entity" => "NIH/NIAID budget", "reason" => "Five cost-plus contracts depend on continued NIH funding; CR or budget cuts would delay option exercises.", "trigger" => "FY2027 NIH budget request, CR duration, NDAA provisions"}